1. Home
  2. WDS vs INSM Comparison

WDS vs INSM Comparison

Compare WDS & INSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WDS
  • INSM
  • Stock Information
  • Founded
  • WDS 1954
  • INSM 1988
  • Country
  • WDS Australia
  • INSM United States
  • Employees
  • WDS N/A
  • INSM N/A
  • Industry
  • WDS Oil & Gas Production
  • INSM Biotechnology: Pharmaceutical Preparations
  • Sector
  • WDS Energy
  • INSM Health Care
  • Exchange
  • WDS Nasdaq
  • INSM Nasdaq
  • Market Cap
  • WDS 28.4B
  • INSM 29.0B
  • IPO Year
  • WDS N/A
  • INSM 2000
  • Fundamental
  • Price
  • WDS $15.08
  • INSM $161.88
  • Analyst Decision
  • WDS Hold
  • INSM Strong Buy
  • Analyst Count
  • WDS 1
  • INSM 19
  • Target Price
  • WDS N/A
  • INSM $152.71
  • AVG Volume (30 Days)
  • WDS 778.8K
  • INSM 2.2M
  • Earning Date
  • WDS 08-18-2025
  • INSM 10-30-2025
  • Dividend Yield
  • WDS 6.77%
  • INSM N/A
  • EPS Growth
  • WDS 58.72
  • INSM N/A
  • EPS
  • WDS 1.54
  • INSM N/A
  • Revenue
  • WDS $13,781,000,000.00
  • INSM $398,105,000.00
  • Revenue This Year
  • WDS N/A
  • INSM $32.44
  • Revenue Next Year
  • WDS N/A
  • INSM $123.99
  • P/E Ratio
  • WDS $9.67
  • INSM N/A
  • Revenue Growth
  • WDS 9.53
  • INSM 21.15
  • 52 Week Low
  • WDS $11.26
  • INSM $60.40
  • 52 Week High
  • WDS $17.76
  • INSM $163.22
  • Technical
  • Relative Strength Index (RSI)
  • WDS 36.76
  • INSM 80.92
  • Support Level
  • WDS $14.93
  • INSM $156.87
  • Resistance Level
  • WDS $15.36
  • INSM $148.22
  • Average True Range (ATR)
  • WDS 0.16
  • INSM 4.33
  • MACD
  • WDS 0.03
  • INSM 0.79
  • Stochastic Oscillator
  • WDS 26.17
  • INSM 98.84

About WDS Woodside Energy Group Limited

Incorporated in 1954 and named after the small Victorian town of Woodside, Woodside's early exploration focus moved from Victoria's Gippsland Basin to Western Australia's Carnarvon Basin. First LNG production from the North West Shelf came in 1984. BHP Billiton and Shell each had 40% shareholdings before BHP sold out in 1994 and Shell sold down to 34%. In 2017 Shell sold its entire shareholding. Woodside is one of the most LNG-leveraged companies globally.

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

Share on Social Networks: